Aucatzyl Purple Book BLA 125813

BLA number
125813
Proprietary names
Aucatzyl
Proper names
Obecabtagene autoleucel
Applicant
Autolus, Inc.
Center
CBER
First observed release
2024-11-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001AucatzylObecabtagene autoleucel351(a)410 × 10^6CAR+ T CELLS TOTAL; DELIVERED AS A SPLIT DOSE IN 3-5 BAGS ON DAY 1 & 10SuspensionIntravenousBagRxLicensed2024-11-08
002AucatzylObecabtagene autoleucel351(a)100 × 10^6CELL/MLSuspensionIntravenousBagRxLicensed2024-11-08
003AucatzylObecabtagene autoleucel351(a)300 × 10^6CELL/MLSuspensionIntravenousBagRxLicensed2024-11-08

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2025-07-01U001Aucatzyl351(a)RxAutolus, Inc.
2025-06-01U001Aucatzyl351(a)RxAutolus, Inc.
2024-12-01U001Aucatzyl351(a)RxAutolus, Inc.
2024-12-01U002Aucatzyl351(a)RxAutolus, Inc.
2024-12-01U003Aucatzyl351(a)RxAutolus, Inc.
2024-11-01N001Aucatzyl351(a)RxAutolus, Inc.
2024-11-01N002Aucatzyl351(a)RxAutolus, Inc.
2024-11-01N003Aucatzyl351(a)RxAutolus, Inc.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2024-11-01001Aucatzyl351(a)RxLicensed2024-11-08
2024-11-01002Aucatzyl351(a)RxLicensed2024-11-08
2024-11-01003Aucatzyl351(a)RxLicensed2024-11-08